Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-β-lactamase

被引:4
作者
el kadi, M. Ait [1 ]
Aghrouch, M.
Seffar, M.
El harti, J.
Bouklouze, A.
Cherrah, Y.
Souly, K.
Zouhdi, M.
机构
[1] CHU Ibn Sina, Hop Special, Microbiol Serv, Rabat, Morocco
[2] Fac Med & Pharm, Lab Pharmacol & Toxicol, Rabat, Morocco
来源
MEDECINE ET MALADIES INFECTIEUSES | 2006年 / 36卷 / 07期
关键词
Acinetobacter baumannii; imipenem; metallo-beta-lactamase; resistance; Pseudomonas aeruginosa;
D O I
10.1016/j.medmal.2006.05.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Metallo-beta-lactamases (MBL) are enzymes produced by Gram-negative bacilli such as Pseudomonas aeruginosa and Acinetobacter baumannii. These enzymes make these isolates resistant to imipenem. Aim. - The aim of this study was to determine the prevalence of this resistance mechanism in Pseudomonas aeruginosa and Acinetobacter baumannii strains identified in the bacteriology laboratory of the Rabat Ibn Sina teaching hospital, Morocco. Materials and method. - Screening for MBL was systematic in all resistant strains and/or strains with decreased sensitivity to imipenem, according to Dongeun Yong et al.'s method, using a sterilized solution of EDTA 0.5 M pH 8. Results. - Eighty-five bacterial strains (48 P. aeruginosa and 37 A. baumannii) were identified 23% (11) and 57% (21) of which were respectively resistant to the imipenem. The prevalence of MPL producing strains was 27% for P aeruginosa and 38% for A. baumannii. Conclusion. - These results show that the frequency of these strains is increases in our hospital and that their emergence represents a serious therapeutic and epidemiological problem. This means that we need to implement the super-vision of hospital microbial environment and strictly apply hygiene measures. (C) 2006 Elsevier SAS.
引用
收藏
页码:386 / 389
页数:4
相关论文
共 9 条
  • [1] Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates
    Altoparlak, U
    Aktas, F
    Celebi, D
    Ozkurt, Z
    Akcay, MN
    [J]. BURNS, 2005, 31 (06) : 707 - 710
  • [2] Standard numbering scheme for class B β-lactamases
    Galleni, M
    Lamotte-Brasseur, J
    Rossolini, GM
    Spencer, J
    Dideberg, O
    Frère, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 660 - 663
  • [3] Lee K, 2003, EMERG INFECT DIS, V9, P868
  • [4] Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa
    Luzzaro, F
    Endimiani, A
    Docquier, JD
    Mugnaioli, C
    Bonsignori, M
    Amicosante, G
    Rossolini, GM
    Toniolo, A
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (02) : 131 - 135
  • [5] Acinetobacter baumannii, the nosocomial pathogen par excellence
    Nordmann, P
    [J]. PATHOLOGIE BIOLOGIE, 2004, 52 (06): : 301 - 303
  • [6] Dissemination and diversity of metallo-β-lactamases in Latin America:: report from the SENTRY Antimicrobial Surveillance Program
    Sader, HS
    Castanheira, M
    Mendes, RE
    Toleman, M
    Walsh, TR
    Jones, RN
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) : 57 - 61
  • [7] TRANSFERABLE IMIPENEM RESISTANCE IN PSEUDOMONAS-AERUGINOSA
    WATANABE, M
    IYOBE, S
    INOUE, M
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 147 - 151
  • [8] Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.
    Yong, DE
    Lee, K
    Yum, JH
    Shin, HB
    Rossolini, GM
    Chong, YS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3798 - 3801
  • [9] Risk factors for imipenem-resistant Pseudomonas aeruginosa:: a comparative analysis of two casecontrol studies in hospitalized patients
    Zavascki, AP
    Cruz, RP
    Goldani, LZ
    [J]. JOURNAL OF HOSPITAL INFECTION, 2005, 59 (02) : 96 - 101